Tumor growth inhibition was statistically significant in mice treated with oAd/APP+DC as compared with individual treatment groups (P < 0.05 versus DCs, P < 0.01 versus oAd/APP, P < 0.05 versus oAd or PBS), respectively. The gene discussed is APP; the disease is neoplasm.